Novoclem Appoints World Leading Experts in Cystic Fibrosis
July 19, 2017
DURHAM, NC (July 19, 2017) Novoclem Therapeutics, Inc., a subsidiary of private life science technology company KNOW Bio, LLC, today announced the appointment of leading experts to its newly formed scientific advisory board. The SAB will serve as a strategic resource to Novoclem as it continues to develop multiple nitric oxide-releasing biopolymers for the treatment of severe respiratory diseases.
Know Bio Respiratory Has New Name, Novoclem Therapeutics
April 11, 2017
Independent Studies Show Nitric Oxide Drug Candidate Extremely Effective in Treating Antibiotic-Resistant Pathogens
DURHAM, NC (April 11, 2017) – Novoclem Therapeutics, a subsidiary of private life science technology company KNOW Bio, LLC, today unveiled its new name and announced that in-vitro studies show its lead drug…
Anne Whitaker Named CEO of KNOW Bio Respiratory Company
Jan 26, 2017
Targets Cystic Fibrosis using Novel Nitric Oxide Technology
DURHAM, N.C., Jan. 26, 2017 / PRNewswire / — KNOW Bio, LLC, a company created in late 2015 from the separation of all non- dermatological assets from Novan, Inc (NASDAQ: NOVN), announces the hiring of Anne Clem Whitaker as CEO of its Respiratory Business. Whitaker is a seasoned bio
Sign up for Email Alerts
Please fill out the form below to receive company press releases via email when they occur.